Delivery Order SPE2DR25D1002-SPE2DR26FGL4T
- Not listed
- The Defense Logistics Agency awarded a $1,078.72 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Gemtesa 75 mg tablets (90-count package). This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 90 tablets of Gemtesa 75 mg, with a ceiling value of $5,400.07 under a firm fixed-price delivery order contract. The award was competitively procured with no set-aside designation and is scheduled for completion by September 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $7,385.86. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a non-competitive award under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled from AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $4,245.95. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $21,981.14 to supply Gemtesa 75 mg tablets (90-count units) under a firm fixed price contract. The contract, issued on December 12, 2025, has an ultimate completion date of December 15, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis and represents a child delivery order under a larger indefinite...
- The Defense Logistics Agency awarded a $17.2K delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This competitive award, which is non-set-aside, represents a firm fixed-price delivery order with performance concluding by December 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for 90 tablets of Gemtesa 75 mg with a ceiling value of $7,551.80 under a Firm Fixed Price contract structure. This is a non-set-aside competitive award with an ultimate completion date of October 30, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $1,533.50 to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Gemtesa 75 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with a completion date of November 19, 2025, and performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical delivery under the agency's medical supply procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $4,606.47. This delivery order represents a firm fixed-price, non-set-aside contract to be completed by September 15, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,196.79 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on November 28, 2025, with an ultimate completion date of December 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGL4TDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,993.41 on December 16, 2025, for the supply of Gemtesa 75 mg tablets in quantities of 30 units. The order, which is not set-aside and was competitively awarded, is scheduled for completion by December 17, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under firm fixed pricing and represents a child contract vehicle stemming from a larger indefinite delivery contract. This award falls under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The company's contract portfolio demonstrates its capability to fulfill diverse federal medical requirements, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 12/15/25 |